# Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks

> **NCT02582996** · PHASE3 · SUSPENDED · sponsor: **Ache Laboratorios Farmaceuticos S.A.** · enrollment: 336 (estimated)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Acetaminophen+Caffeine+Dihydroergotamine+Metoclopramide.
- **DRUG:** Acetaminophen

## Key facts

- **NCT ID:** NCT02582996
- **Lead sponsor:** Ache Laboratorios Farmaceuticos S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-04
- **Primary completion:** 2021-04
- **Final completion:** 2021-06
- **Target enrollment:** 336 (ESTIMATED)
- **Why stopped:** Strategic reasons of the company
- **Last updated:** 2019-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02582996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02582996, "Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02582996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*